Schwartz, Daniella M.
Bonelli, Michael
Gadina, Massimo
O'Shea, John J.
Article History
First Online: 3 December 2015
Competing interests
: J.J.O'S. declares that he and the US Government receive royalties based on patents related to targeting Janus kinases. J.J.O'S. and M.G. and the US Government have had longstanding Cooperative Research and Development Agreements with Pfizer, which produces tofacitinib, a Janus kinase inhibitor.
Free to read: This content has been made available to all.